Exploring the Immune Mechanisms of Leprosy and Dermatophytosis Coexistencehttps://www.leprosy-information.org/resource/exploring-immune-mechanisms-leprosy-and-dermatophytosis-coexistence1767225600Jaodand A, Morgaonkar M, Gupta SPowered by InfolepInnate-adaptive immune crosstalk: TLR2 expression and CD8+ memory T cell responses in leprosyhttps://www.leprosy-information.org/resource/innate-adaptive-immune-crosstalk-tlr2-expression-and-cd8-memory-t-cell-responses-leprosy1767225600Rodrigues-Menezes Y, Chebli-de-Abreu N, Macedo JM, et alPowered by InfolepAntimicrobial resistance surveillance: a crucial pillar for sustainable leprosy control and chemoprophylaxis.https://www.leprosy-information.org/resource/antimicrobial-resistance-surveillance-crucial-pillar-sustainable-leprosy-control-and1767225600Fastenau A, Avanzi C, Ortuño-Gutiérrez N, et alPowered by InfolepLeprosy in Sudan: What is the current situation?https://www.leprosy-information.org/resource/leprosy-sudan-what-current-situation1735689600Niyle RM, Salium JAA, Eltahir MS, et alPowered by InfolepGuidelines_Rifampicin Stock Managementhttps://www.leprosy-information.org/resource/guidelinesrifampicin-stock-management1767225600Powered by InfolepSDR-PEP calculation tool for ordering rifampicinhttps://www.leprosy-information.org/resource/sdr-pep-calculation-tool-ordering-rifampicin1767225600NLR Powered by InfolepGD06 Single-dose rifampicin for control of leprosy transmission: rollout and navigating funding challenges in Nepalhttps://www.leprosy-information.org/resource/gd06-single-dose-rifampicin-control-leprosy-transmission-rollout-and-navigating-funding1767225600Baskota R, Sunar CPowered by InfolepRisk Factors Associated With Time to Disease Onset Among Leprosy Contacts: A Cohort-Based Survival Analysishttps://www.leprosy-information.org/resource/risk-factors-associated-time-disease-onset-among-leprosy-contacts-cohort-based-survival1767225600de Alecrin E, Martins M, Oliveira D, et alPowered by InfolepAccelerating vaccine research and development for skin neglected tropical diseases: A case for leishmaniasis, leprosy, and Buruli ulcerhttps://www.leprosy-information.org/resource/accelerating-vaccine-research-and-development-skin-neglected-tropical-diseases-case1767225600Wang H, Novais F, Gómez M, et alPowered by Infolep‘Blanket approach’ or community-wide PEP implementation for leprosy: When, Where and How? Report on an expert meeting 23 September 2023https://www.leprosy-information.org/resource/blanket-approach-or-community-wide-pep-implementation-leprosy-when-where-and-how-report1735689600Mieras L, Bakker MI, Banstola NL, et alPowered by Infolep